ÄÜÅÙÃ÷ »ó¼¼º¸±â
Äڷγª-19 Áúº´ ½É°¢µµ¿Í °ü·ÃµÈ ±âÁ¸ Ư¼º


Äڷγª-19 Áúº´ ½É°¢µµ¿Í °ü·ÃµÈ ±âÁ¸ Ư¼º

Äڷγª-19 Áúº´ ½É°¢µµ¿Í °ü·ÃµÈ ±âÁ¸ Ư¼º

,< Natalie Achamallah>,< Hongwei Ji>,< Brian L. Claggett6>,< Nancy Sun>,< Patrick | ¾ÆÁø

Ãâ°£ÀÏ
2020-09-18
ÆÄÀÏÆ÷¸Ë
ePub
¿ë·®
11 M
Áö¿ø±â±â
PC½º¸¶Æ®ÆùÅÂºí¸´PC
ÇöȲ
½Åû °Ç¼ö : 0 °Ç
°£·« ½Åû ¸Þ¼¼Áö
ÄÜÅÙÃ÷ ¼Ò°³
¸ñÂ÷
ÇÑÁÙ¼­Æò

ÄÜÅÙÃ÷ ¼Ò°³

¾î¶² »ç¶÷µéÀº »ç½º-CoV-2¿¡ °¨¿°µÇ¾úÀ» ¶§, ºÒºÐ¸íÇÑ ÀÌÀ¯·Î ´õ ½É°¢ÇÑ ÇüÅÂÀÇ Covid-19 º´¿¡ °É¸®´Â °æÇâÀÌ ÀÖ´Ù. ÀÌ ³í¹®Àº Covid-19 °¨¿°ÀÇ ½É°¢µµ Áõ°¡¿Í °ü·ÃµÈ Àα¸Åë°èÇÐÀû ¹× ÀÓ»óÀû Ư¼º¿¡ ´ëÇÏ¿© ÀÛ¼ºÇÏ¿´´Ù. ¶ÇÇÑ, ȯÀÚ¿¡ ´ëÇÏ¿© ȸ°íÀû °üÂû ¿¬±¸. ÀüÀÚ °Ç°­ ±â·Ï¿¡¼­ µ¥ÀÌÅ͸¦ ¼öÁýÇÏ°í ´Ùº¯·® ·ÎÁö½ºÆ½ ȸ±Í ºÐ¼®À» »ç¿ëÇÏ¿© ÇÊ¿äÇÑ Ä¡·á ¼öÁØ(º´¿ø ÀÔ¿ø ÇÊ¿ä, ÁýÁß Ä¡·á ÇÊ¿ä, »ð°ü ÇÊ¿ä)¿¡ µû¶ó Á¤ÀÇµÈ Covid-19 Áúº´ ½É°¢µµ¿Í ±âÁ¸ Ư¼ºÀÇ ¿¬°ü¼ºÀ» °Ë»çÇß´Ù.

¸ñÂ÷

Á¦ 1Æí Äڷγª¹ÙÀÌ·¯½º Á¤ÀÇ

1. Äڷγª¹ÙÀÌ·¯½º°¨¿°Áõ-19(Covid-19) Á¤º¸ 7
2. Äڷγª¹ÙÀÌ·¯½º ºÐ·ù ¹× Ư¼º 9
3. Äڷγª¹ÙÀÌ·¯½º ÀüÀÚÇö¹Ì°æ ÇüÅ 11
4. Äڷγª¹ÙÀÌ·¯½º ±¸Á¶ (Covid-19 Organization) 13
5. Äڷγª19: ȯ°æ¿¡ Áö¼ÓÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥±î? 19
6. Ä¡·á¹ý(Therapeutical Method) 22



Á¦ 2Æí ¿¬±¸³í¹®
Pre-existing traits associated with Covid-19 illness severity


1. Introduction 24
2. Methods 25
3. Statistical analyses 26
4. Results 26
5. Discussion 30
6. References 34